Breast: Page 53

Novarad to distribute CureMetrix mammo AI software
By AuntMinnie.com staff writers
Healthcare IT company Novarad is set to be the exclusive distributor of CureMetrix artificial intelligence (AI) mammography software at small and medium-sized imaging centers and hospitals.
November 27, 2021
2021 11 28 19 16 4201 2021 11 28 Nova Mg Pro With Cure Metrix 20211128192643
DBT maintains screening benefits over time
By Amerigo Allegretto
Digital breast tomosynthesis (DBT) has shown itself to be a valid, beneficial breast imaging technology over a decade after it first became commercially available, according to research presented Sunday at the RSNA 2021 annual meeting.
November 27, 2021
2021 11 28 17 59 0994 Rsna 2021 Welcome 400
FDA clears Therapixel mammo AI software for tomosynthesis
By AuntMinnie.com staff writers
French artificial intelligence (AI) software developer Therapixel's MamoScreen software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with digital breast tomosynthesis.
November 27, 2021
2021 04 22 16 35 1971 Breast Mammo Computer 400
Deep-learning tool triages women with decreased breast density
By Amerigo Allegretto
Wednesday, December 1 | 3:00 p.m.-4:00 p.m. | SSBR09-4 | Room S406BIn this Wednesday talk, researchers will present findings from their study of nearly 2,700 women that used a convolutional neural network in predicting mammographic density percentage from MRI scans.
November 23, 2021
Combining radiomics, AI with PET/MRI helps assess nodal status
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room N226Researchers will discuss in this Sunday session how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.
November 23, 2021
PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 23, 2021
QView software to launch from GE's ABUS scanner
By AuntMinnie.com staff writers
Software from computer-aided detection (CAD) software developer QView Medical can now be launched from GE Healthcare's automated breast ultrasound (ABUS) scanner, the Invenia ABUS 2.0.
November 22, 2021
2019 07 12 00 07 3354 Breast Ultrasound 400
Combining radiomics, AI with PET/MRI helps assess nodal status
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room N226Here, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.
November 22, 2021
PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 22, 2021
PET with F-18 fluoroestradiol tracer evaluated in women with breast cancer
By Will Morton
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-2 | Room N226In this talk, researchers will discuss results of the first prospective study evaluating the performance of F-18 fluoroestradiol PET/CT in women with invasive lobular carcinoma breast cancer.
November 22, 2021
2017 11 07 18 37 9362 Roadies Ribbon 400
Breast MRI shows effects of IUDs on body
By Amerigo Allegretto
Breast MRI shows that intrauterine contraceptive devices (IUDs) have systemic effects on the body and not just the uterus. The phenomenon could affect the accuracy of breast MRI, according to research being presented at the RSNA 2021 annual meeting.
November 21, 2021
2021 11 19 23 54 6612 2021 11 22 Huck Breast Mri Iu Ds 400
Should women over 75 continue to get breast screening?
By Amerigo Allegretto
For how long should older women continue to receive breast screening? Most guidelines suggest stopping at age 75, but would women benefit from screening after that? A new study published November 22 in the Annals of Internal Medicine offers some guidance.
November 21, 2021
2020 06 15 23 55 8696 Patient Elderly Woman 400
Previous Page
Page 53 of 573
Next Page